Our cost effective and comprehensive travel service offers a convenient one stop for all your travel certification needs
- No Referral Necessary
- You are seen by an experienced doctor and swabs are collected
- Your test results and detailed travel certication will be emailed to you in 24 hours.
Special Travel requirements
Travellers to China
Effective from 8th November 2020, all travellers to China will be required to have a Negative COVID-19 IgM antibody blood test and a Negative COVID-19 PCR swab test. The samples need to be collected from the patient 2 days prior to boarding. We are able to offer COVID-19 IgM antibody blood test in addition to the COVID-19 PCR test for all travellers to China as well as the required travel certification.
Travellers to Japan
Effective from 15th January 2021, all travellers to Japan will be required to have a Negative COVID-19 RT-PCR swab test. The samples need to be collected from the patient 72 hours prior to departure. We are able to offer this test for all travellers to Japan as well as the required travel certification.
Travellers to India
Effective from 21st October 2020, travellers to India requiring a Negative COVID-19 RT-PCR swab test. The swab needs to be collected no more than 72 hours prior to departure. We are able to offer this test for all travellers to India as well as the required travel certification.
COVID-19 (IgG/IgM) Rapid Antibody Test
We offer this innovative, all-in-one point of care test for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 virus in whole blood, serum, or plasma samples.
This test is essential for travellers to China and also useful to any one who needs to know their previous exposure to the COVID virus.
Unlike standard multi-component rapid test kits, the AtomoRapid COVID-19 (IgG/IgM) Rapid Antibody Test is a single-use, integrated device that gives an accurate result in just 15 minutes.
Intended for identifying persons who may have been exposed and developed an immune response to the SARS-CoV-2 virus, the test is entered in the Australian Register of Therapeutic Goods ARTG 341411 and is available now in Australia for use by healthcare professionals.
Developed in partnership with French biotechnology specialist NG Biotech, the AtomoRapidTM COVID-19 (IgG/IgM) Rapid Antibody Test has demonstrated excellent performance in multiple independent clinical evaluations internationally.
The AtomoRapidTM COVID-19 (IgG/IgM) Rapid Antibody Test incorporates Atomo’s award-winning ‘Galileo’ integrated diagnostic test platform – designed and developed in Australia – for peerless safety and utility.